PubRank

Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (READT)

Clinical Trial ID NCT03703778

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03703778

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation 2010 3.16
2 Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer? Oncology (Williston Park) 2010 2.73
3 Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 2009 1.90
4 Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009 1.86
5 Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol 2006 1.04
6 Treatment-related diabetes and cardiovascular disease in prostate cancer survivors. Ann Oncol 2008 0.83
7 Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population. J Diabetes 2014 0.79
8 Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective. Asian J Androl 2012 0.79
9 Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer. Asian J Androl 2015 0.78
10 Menopause in German and Chinese women--an analysis of symptoms, TCM-diagnosis and hormone status. Chin J Integr Med 2008 0.78
11 Bone complications of androgen deprivation therapy: screening, prevention, and treatment. Curr Opin Urol 2010 0.77
12 Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong. Jpn J Clin Oncol 2015 0.76
13 Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population. BJU Int 2015 0.75
Next 100